[1] SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209. doi: 10.3322/caac.21660
[2] MCDONALD ES, CLARK AS, TCHOU J, et al. Clinical diagnosis and management of breast cancer[J]. J Nucl Med, 2016(57 Suppl 1): 9S.
[3] NASER AL, DEEN N, NASSAR F, et al. Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability[J]. Adv Exp Med Biol, 2019, 1152: 335.
[4] YU DD, WU Y, SHEN HY, et al. Exosomes in development, metastasis and drug resistance of breast cancer[J]. Cancer Sci, 2015, 106(8): 959. doi: 10.1111/cas.12715
[5] WANG D, WANG X, SI M, et al. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J]. Cancer Lett, 2020, 474: 36. doi: 10.1016/j.canlet.2020.01.005
[6] KALLURI R, LEBLEU VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977. doi: 10.1126/science.aau6977
[7] PERONE Y, FARRUGIA AJ, RODRÍGUEZ-MEIRA A, et al. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer[J]. Nat Commun, 2019, 10(1): 2115. doi: 10.1038/s41467-019-09676-y
[8] YUAN X, QIAN N, LING S, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells[J]. Theranostics, 2021, 11(3): 1429. doi: 10.7150/thno.45351
[9] PAN X, HONG X, LAI J, et al. Exosomal MicroRNA-221-3p confers adriamycin resistance in breast cancer cells by targeting PIK3R1[J]. Front Oncol, 2020, 10: 441. doi: 10.3389/fonc.2020.00441
[10] CHEN R, QIAN Z, XU X, et al. Exosomes-transmitted miR-7 reverses gefitinib resistance by targeting YAP in non-small-cell lung cancer[J]. Pharmacol Res, 2021, 165: 105442.
[11] SANTOS JC, LIMA NDS, SARIAN LO, et al. Exosome-mediated breast cancer chemoresistance via miR-155 transfer[J]. Sci Rep, 2018, 8(1): 829.